Emcure Pharmaceuticals Ltd.

NSE: EMCURE | BSE: 544210

Download real time

905.60 -37.25 (-3.95%)

New 52W Low in past week

92,307 NSE+BSE Volume

NSE 09 Apr, 2025 3:31 PM (IST)

17,159.6

Market Cap

High in industry

-

Beta 1Year

Emcure Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Emcure Pharmaceuticals Ltd. on BSE

Load latest

Emcure Pharmaceuticals Ltd.

06 Feb 2025

905.60

-3.95%

Earnings Call

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio recording of the call held today i.e. on February 06, 2025, is available on our website.

Emcure Pharmaceuticals Ltd.

06 Feb 2025

905.60

-3.95%

Emcure Pharmaceuticals Results Earnings Call for Q3FY25

Conference Call with Emcure Pharmaceuticals Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Emcure Pharmaceuticals Ltd.

06 Feb 2025

905.60

-3.95%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Disclosure under Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015

Emcure Pharmaceuticals Ltd.

06 Feb 2025

905.60

-3.95%

Corp. Note

Emcure Pharmaceuticals Ltd - 544210 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024

Emcure Pharmaceuticals Ltd.

06 Feb 2025

905.60

-3.95%

Board Meeting

Emcure Pharmaceuticals Ltd - 544210 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board Meeting held on February 06, 2025

Emcure Pharmaceuticals Ltd.

06 Feb 2025

905.60

-3.95%

to see Rapid results content

Emcure Pharmaceuticals Ltd.

06 Feb 2025

905.60

-3.95%

Result

Emcure Pharmaceuticals Ltd - 544210 - Unaudited Financial Results (Consolidated And Standalone) For The Quarter And …

BSE India

Unaudited Financial Results (Consolidated & Standalone) For the quarter and nine months ended December 31, 2024

Emcure Pharmaceuticals Ltd.

05 Feb 2025

905.60

-3.95%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure regarding an Order received by the Company on February 05, 2025

Emcure Pharmaceuticals Ltd.

05 Feb 2025

905.60

-3.95%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure regarding Orders received by the Company and its subsidiary on February 05, 2025

Emcure Pharmaceuticals Ltd.

24 Jan 2025

905.60

-3.95%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that the Earnings Call for Investors/ Analysts will be held on Thursday, February 06, 2025 at 5:30 p.m. (IST) to discuss the Company''s unaudited financial results (standalone and consolidated) and performance for the quarter and nine months ended December 31, 2024.

No results found

RESEARCH REPORTS

IPO Note SEE REPORTS >